Skip to main content

Quality Policy

Commitment & Accountabilities

SGD Pharma is committed to protecting and improving patient health by providing high quality, reliable and innovative products to our customers in the pharmaceutical industry.

Part of our mission is putting patient health as the top priority when we are making decisions.

All employees and external contributors work to meet SGD Pharma quality objectives. Each participant involved in the production of our glass vials, bottles and ampoules is held directly responsible for the quality of the product that is being made.

Foundations

Put our customers at the heart of our priorities

  • Ensure that each employee understands the needs of our customers and the pharmaceutical industry.
  • Be recognized by our customers for reliability in the quality of our products and service.
  • Provide fast and efficient technical support.

Incorporate the requirements of the pharmaceutical industry

  • Maintain ISO 15378 certification at all our sites, according to the rules of Good Manufacturing Practices applicable to primary packaging in the pharmaceutical industry.
  • Verify the proper application of relevant regulations and standards at appropriate intervals.
  • Be vigilant with regard to regulatory changes related to bottles in the pharmaceutical industry through proactive monitoring.

Develop our skills

  • Ensure that each employee is fully aware of SGD Pharma’s quality objectives and takes an active part in achieving the targets set.
  • Regularly evaluate employee skills and qualifications and plan the actions necessary to ensure that an adequate level is maintained.
  • Train each employee to build on their skills to achieve our required quality objectives.

Move towards zero defects

  • Complete quality performance reviews at Group level and at each site to define an action plan, taking into account data analysis and the results of quality and customer service indicators.
  • Evaluate the risks of non-conformity by using adapted tools (change control, FMEA study), allowing the implementation of preventive actions.
  • Improve the robustness of our processes by systematically using problem-solving methods.
Olivier Rousseau Olivier Rousseau

Chief Executive Officer

Signature
Christophe Muguet Christophe Muguet

Chief Operating Officer

Signature
Laurent Millet Laurent Millet

Group Quality Director

Signature
Corporate-strategy

Corporate Strategy

Discover SGD Pharma corporate strategy, mission and values.

Read more
Innovation

Innovations

One of the keys to SGD Pharma’s leadership position in the glass industry has always been its drive to continually innovate.

Read more
Type I molded glass vials

Type I molded glass vials

Our Type I molded glass vials safeguard sensitive injectable drugs…

Read more